The point is that we currently have a vaccine that eradicates those types of cancers but we have very low numbers of people willing to take the vaccine because of cultural hesitancy

I would quibble with your definition of "very low", given that the number is >50% in the US.

I agree we have a preventative treatment for a cancer and not everyone takes it. What conclusions do you draw from this point as it relates to this thread (or in general)?

Personally, I'm surprised that uptake is so fast for a relatively new and elective treatment. Even moreso when considering that it addresses a rare disease that effects people many decades later.

Do you have a source for that? Because my understanding is that even in young people (the original CDC target for the vaccine), the vaccination rate is under 50% in the US.

https://www.cdc.gov/hpv/partners/outreach-hcp/hpv-coverage.h....

Here is a more recent link from the CDC that puts it at 75% started and 58% complete for adolescents.[1]

This isn't surprising because the CDC shows adoption going up a few percent per year. This year over year increase is more or less what you would expect given we are still in the adoption phase of this new medicine.[2] Eventually this increase will stall out with some people refusing to use it, but we aren't there yet.

https://www.cdc.gov/mmwr/volumes/70/wr/mm7035a1.htm

https://www.cdc.gov/nchs/products/databriefs/db354.htm

"for adolescents" is an important qualifier. Seems like the eligible population is still way under 50%.